Harnessing BDNF Signaling to Promote Resilience in Aging DOI Open Access
Jamshid Faraji, Gerlinde A. S. Metz

Published: July 29, 2024

As a key member of the neurotrophin family in central nervous system, brain-derived neurotrophic factor (BDNF) plays critical role maintenance and plasticity system. Its innate neuroprotective advantage can also be shared with brain when normal aging-dependent processes challenge neural circuits. The intricate relationship between BDNF resilience during aging process signifies molecular mechanisms that underlie protection function, such as cognition, movement psychological well-being. is crucial for neuronal growth survival, it promote against age-related functional decline frailty, even if fails to entirely prevent ageing-related decline. In present review, we discuss function from perspective how may aging. We emphasize briefly principal, well-known cellular hallmarks restrict disabling dynamics enhance overall Insight into pathways through which reduces dysfunctions and/or improves resilience, provide foundation developing targeted interventions mental well-being an population.

Language: Английский

COVID-19 Affects Serum Brain-Derived Neurotrophic Factor and Neurofilament Light Chain in Aged Men: Implications for Morbidity and Mortality DOI Creative Commons
Carla Petrella, Maria Antonella Zingaropoli, Flavio Maria Ceci

et al.

Cells, Journal Year: 2023, Volume and Issue: 12(4), P. 655 - 655

Published: Feb. 17, 2023

Background and Methods: Severe COVID-19 is known to induce neurological damage (NeuroCOVID), mostly in aged individuals, by affecting brain-derived neurotrophic factor (BDNF), matrix metalloproteinases (MMP) 2 9 the neurofilament light chain (NFL) pathways. Thus, aim of this pilot study was investigate BDNF, MMP-2, MMP-9, NFL serum men affected at beginning hospitalization period characterized different outcomes, i.e., attending a hospital ward or an intensive care unit (ICU) with fatal outcome. As control group, we used novelty study, unexposed age-matched men. We also correlated these findings routine blood parameters recruited individuals. Results: found individuals severe lethal outcomes disrupted NFL, MMP-2 presence gross changes ALT, GGT, LDH, IL-6, ferritin, CRP. confirmed extended previous data, using ROC analyses, showing that ratio MMPs (2 9) versus BDNF might be useful tool predict Conclusions: Serum and/or their ratios MMP-9 could represent early predictors NeuroCOVID

Language: Английский

Citations

21

A highly sensitive enzyme‑linked immunosorbent assay allows accurate measurements of brain‑derived neurotrophic factor levels in human saliva DOI Creative Commons

Fumie Akutsu,

Shiro Sugino,

Mitsuo Watanabe

et al.

F1000Research, Journal Year: 2025, Volume and Issue: 14, P. 161 - 161

Published: Feb. 4, 2025

Background Hitherto, BDNF levels in humans have been primarily measured serum and/or plasma where these are readily measurable, but reflect the content of blood platelets. By contrast, previous attempts to measure accessible human body fluids such as saliva complicated by a lack sensitivity specificity ELISAs (see Discussion). Recently, suitability highly sensitive ELISA assay was validated using mouse and conventional fail detect BDNF. In this report, we demonstrate that extremely low, low pg/mL range, yet detectable all samples tested. Methods Saliva were collected from healthy volunteers passive drool method. All aliquoted immediately frozen keep at -80°C until use. At time use, thawed, centrifuged remove any remaining particles measurement conducted previously below). Recombinant mature used reference. Results The intra-assay variability range CV = 1.8 4.9%. could be kept for 2 months use measurements, more than 4 freeze thaw cycles caused losses presumably due structural change antigen. measurements not affected method collection provided diluted least 2-fold. Conclusions results indicate non-invasive fashion can source material try correlate with conditions interest. These also confirm those an independent study published recently same kit samples.

Language: Английский

Citations

0

Role of Neurotrophins in Orofacial Pain Modulation: A Review of the Latest Discoveries DOI Open Access
Francesca Bonomini, Gaia Favero,

Stefania Castrezzati

et al.

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(15), P. 12438 - 12438

Published: Aug. 4, 2023

Orofacial pain represents a multidisciplinary biomedical challenge involving basic and clinical research for which no satisfactory solution has been found. In this regard, trigeminal is described as one of the worst pains perceived, leaving patient with hope future. The aim review to evaluate latest discoveries on involvement neurotrophins in orofacial nociception, describing their role expression peripheral tissues, ganglion, nucleus considering double nature “supporters” nervous system “promoters” nociceptive transmission. order scan recent literature (last ten years), three independent researchers referred databases PubMed, Embase, Google Scholar, Scopus, Web Science find original articles trials. selected 33 papers: 29 4 results obtained by screening show an interesting trend, precise modulation neurotrophin signaling could switch from being “promoter” beneficial neurotrophic supporting nerves recovery, especially when structural alteration present, neuropathic pain. conclusion, be targets but more studies are necessary clarify future application practice.

Language: Английский

Citations

8

Levels of brain-derived neurotrophic factor (BDNF) among patients with COVID-19: a systematic review and meta-analysis DOI
Arman Shafiee, Niloofar Seighali,

Mohammad Teymouri Athar

et al.

European Archives of Psychiatry and Clinical Neuroscience, Journal Year: 2023, Volume and Issue: 274(5), P. 1137 - 1152

Published: Aug. 30, 2023

Language: Английский

Citations

7

Intranasal Multiepitope PD‐L1‐siRNA‐Based Nanovaccine: The Next‐Gen COVID‐19 Immunotherapy DOI Creative Commons
Rita C. Acúrcio, Ron Kleiner, Daniella Vaskovich‐Koubi

et al.

Advanced Science, Journal Year: 2024, Volume and Issue: 11(40)

Published: Aug. 8, 2024

Abstract The first approved vaccines for human use against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) are nanotechnology‐based. Although they modular, rapidly produced, and can reduce disease severity, the currently available restricted in preventing infection, stressing global demand novel preventive vaccine technologies. Bearing this mind, we set out to develop a flexible nanovaccine platform nasal administration induce mucosal immunity, which is fundamental optimal protection virus infection. next‐generation multiepitope nanovaccines co‐deliver immunogenic peptides, selected by an immunoinformatic workflow, along with adjuvants regulators of PD‐L1 expression. As case study, focused on SARS‐CoV‐2 peptides as relevant antigens validate approach. This evoke both local systemic cellular‐ humoral‐specific responses SARS‐CoV‐2. led secretion immunoglobulin A (IgA), capable neutralizing SARS‐CoV‐2, including variants concern, following heterologous immunization strategy. Considering limitations required cold chain distribution current nanotechnology‐based vaccines, it shown that lyophilized stable long‐term at room temperature retains its vivo efficacy upon reconstitution. makes particularly developing countries offers modular system adaptable future viral threats.

Language: Английский

Citations

2

Harnessing BDNF Signaling to Promote Resilience in Aging DOI Creative Commons
Jamshid Faraji, Gerlinde A. S. Metz

Aging and Disease, Journal Year: 2024, Volume and Issue: unknown, P. 0 - 0

Published: Jan. 1, 2024

As a key member of the neurotrophin family in central nervous system, brain-derived neurotrophic factor (BDNF) plays critical role maintenance and plasticity system. Its innate neuroprotective advantage can also be shared with brain when normal aging-dependent processes challenge neural circuits. The intricate relationship between BDNF resilience during aging process signifies molecular mechanisms that underlie protection function, such as cognition, movement psychological well-being. is crucial for neuronal growth survival, it promote against age-related functional decline frailty, even if fails to entirely prevent aging-related decline. In present review, we discuss function from perspective how may aging. We emphasize briefly principal, well-known cellular hallmarks restrict disabling dynamics enhance overall Insight into pathways through which reduces dysfunctions and/or improves resilience, provides foundation developing targeted interventions mental well-being an population.

Language: Английский

Citations

2

Neuroprotective Agents with Therapeutic Potential for COVID-19 DOI Creative Commons

César A. Zaa,

Clara Espitia, Karen Lizbeth Reyes-Barrera

et al.

Biomolecules, Journal Year: 2023, Volume and Issue: 13(11), P. 1585 - 1585

Published: Oct. 27, 2023

COVID-19 patients can exhibit a wide range of clinical manifestations affecting various organs and systems. Neurological symptoms have been reported in patients, both during the acute phase illness cases long-term COVID. Moderate include ageusia, anosmia, altered mental status, cognitive impairment, more severe manifest as ischemic cerebrovascular disease encephalitis. In this narrative review, we delve into neurological associated with COVID-19, well underlying mechanisms contributing to them. These direct damage neurons, inflammation, oxidative stress, protein misfolding. We further investigate potential small molecules from natural products offer neuroprotection models neurodegenerative diseases. Through our analysis, discovered that flavonoids, alkaloids, terpenoids, other compounds neuroprotective effects by modulating signaling pathways known be impacted COVID-19. Some these also directly target SARS-CoV-2 viral replication. Therefore, origin show promise agents prevent or mitigate nervous system patients. Further research evaluation different stages are warranted explore their benefits.

Language: Английский

Citations

5

Neuropathic Corneal Pain after Coronavirus Disease 2019 (COVID-19) Infection DOI Creative Commons
Natalie Shi Qi Wong, Chang Liu,

Molly Tzu-Yu Lin

et al.

Diseases, Journal Year: 2024, Volume and Issue: 12(2), P. 37 - 37

Published: Feb. 9, 2024

Introduction: This is a case report of patient with neuropathic corneal pain after coronavirus disease 2019 (COVID-19) infection. Methods: A previously healthy 27-year-old female presented bilateral eye accompanied by increased light sensitivity 5 months COVID-19 She was diagnosed based on clear corneas without fluorescein staining, alongside the presence microneuromas, dendritic cells, and activated stromal keratocytes identified bilaterally in vivo confocal microscopy. Results: The patient’s tear nerve growth factor, substance P, calcitonin gene-related peptide levels were 5.9 pg/mL, 2978.7 1.1 ng/mL, respectively, for right 23.1 4798.7 1.2 left eye, suggesting neuroinflammatory status. After 6 weeks topical 0.1% flurometholone treatment, decreased microneuroma size, less extensive reduced factor P observed. scores Ocular Pain Assessment Survey showed an improvement burning sensation sensitivity, decreasing from 80% 70% to 50% both. Conclusions: Neuropathic potential post-COVID-19 complication that warrants ophthalmologists’ neurologists’ attention.

Language: Английский

Citations

1

Brain neurotrophic factor BDNF: new data, functions and questions DOI Creative Commons
Maryana Zhivkovich, Elizaveta V. Ermolaeva, Alesya V. Soboleva

et al.

Genes and Cells, Journal Year: 2024, Volume and Issue: 19(1), P. 61 - 84

Published: Feb. 26, 2024

The brain-derived neurotrophic factor (BDNF) is a key modulator of neurogenesis, synaptogenesis, neuroregeneration, and cell differentiation in the nervous system. Impaired BDNF functioning characteristic various neurological diseases, such as Alzheimer’s disease, multiple sclerosis, depressive disorders. There recent evidence that patients with COVID-19 have reduced levels blood plasma. Furthermore, exogenous its mimetics demonstrated therapeutic potential. In this review, we systematized data gene structure, epigenetic microRNA-mediated regulation expression, transcriptional variants BDNF, effects on neuronal oligodendroglial differentiation. Further, point out gaps current knowledge about propose experiments can expand range possibilities for using biomedicine. These include determining expression pattern all transcripts at different stages subpopulations studying role receptor-independent signaling, circadian fluctuations levels, their physiological pathophysiological conditions. Finally, translational medicine, evaluating effect (including those immobilized three-dimensional scaffolds tissue engineering) pluripotent polypotent cells identifying molecular regulators transcription, including small molecules microRNAs capable regulating are crucial.

Language: Английский

Citations

1

Nerve Growth Factor and Brain-Derived Neurotrophic Factor in COVID-19 DOI Creative Commons
Carla Petrella, Giampiero Ferraguti, Luigi Tarani

et al.

Biology, Journal Year: 2024, Volume and Issue: 13(11), P. 907 - 907

Published: Nov. 7, 2024

Neurotrophins (NTs) constitute a family of small protein messengers that play fundamental role in both the central and peripheral nervous systems. In particular, nerve growth factor (NGF) brain-derived neurotrophic (BDNF) subtle survival, differentiation, functioning neuronal populations, as well fine regulation immune functions. The SARS-CoV-2 infection was characterized by sequela symptoms (serious respiratory pathology, inflammatory storm, neurological discomfort, up to less serious flu-like symptoms), which caused, at end 2023, more than 7 million deaths worldwide. Despite official pandemic, physical psychological consequences are currently object scientific research, acute chronic/long-lasting (Long-COVID-19). Given multifactorial nature outcomes adults children, several studies have investigated potential involvement NGF BDNF systems pathology. This narrative review aims summarize most recent evidence on this crucial topic.

Language: Английский

Citations

1